Literature DB >> 12492739

Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study.

K Higuchi1, Y Fujiwara, K Tominaga, T Watanabe, M Shiba, S Nakamura, N Oshitani, T Matsumoto, T Arakawa.   

Abstract

BACKGROUND: In Helicobacter pylori infection, the effect of short-term triple therapy with proton pump inhibitor plus two antibiotics on gastric ulcer healing is not well known. AIM: To compare 1-week triple therapy with 8-week proton pump inhibitor therapy on gastric ulcer healing in infected patients. PATIENTS AND METHODS: We randomly assigned 120 patients with H. pylori and gastric ulcers to proton pump inhibitor plus amoxicillin and clarithromycin for 1 week (n = 61) or proton pump inhibitor alone for 8 weeks (n = 59), with endoscopic assessment of ulcer healing 8 weeks after the start of treatment.
RESULTS: Triple therapy eradicated H. pylori in 51 patients [intention-to-treat, 84%; 95% confidence interval (CI), 75-93%]. At 8 weeks, gastric ulcers were healed in 30 patients given triple therapy (49%; 95% CI, 37-62%) and in 49 patients given proton pump inhibitor (83%; 95% CI, 73-93%, P < 0.001). Healing rates in the triple therapy and proton pump inhibitor-only groups were 89% and 100%, respectively, for ulcers of < 1.0 cm in diameter, 54% and 77% for ulcers of 1.0 to < 1.5 cm in diameter, and 5% and 77% (P < 0.001) for ulcers of > or = 1.5 cm in diameter.
CONCLUSIONS: One-week triple therapy healed most ulcers of < 1.0 cm, but not ulcers of > or = 1.5 cm. Short-term therapy is effective for gastric ulcers of < 1.0 cm, but, for larger ulcers, follow-up therapy to suppress acid is needed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12492739     DOI: 10.1046/j.1365-2036.2003.01402.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  13 in total

Review 1.  15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications.

Authors:  Tetsuo Arakawa; Kazuhide Higuchi; Yasuhiro Fujiwara; Toshio Watanabe; Kazunari Tominaga; Eiji Sasaki; Nobuhide Oshitani; Toshikazu Yoshikawa; Andrzej S Tarnawski
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

2.  Is the new potent acid-inhibitory drug vonoprazan effective for healing idiopathic peptic ulcers? A multicenter observational study in Akita Prefecture, Japan.

Authors:  Kae Sugawara; Shigeto Koizumi; Yohei Horikawa; Nobuya Mimori; Tsuyotoshi Tsuji; Hajime Ishii; Shusei Fujimori; Kengo Onochi; Hiroyuki Watanabe; Katsunori Iijima
Journal:  J Gastroenterol       Date:  2019-04-29       Impact factor: 7.527

3.  Evidence-based clinical practice guidelines for peptic ulcer disease 2015.

Authors:  Kiichi Satoh; Junji Yoshino; Taiji Akamatsu; Toshiyuki Itoh; Mototsugu Kato; Tomoari Kamada; Atsushi Takagi; Toshimi Chiba; Sachiyo Nomura; Yuji Mizokami; Kazunari Murakami; Choitsu Sakamoto; Hideyuki Hiraishi; Masao Ichinose; Naomi Uemura; Hidemi Goto; Takashi Joh; Hiroto Miwa; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-02-15       Impact factor: 7.527

4.  [Clinical practice guideline on the management of patients with dyspepsia. Update 2012].

Authors:  Javier P Gisbert; Xavier Calvet; Juan Ferrándiz; Juan Mascort; Pablo Alonso-Coello; Mercè Marzo
Journal:  Aten Primaria       Date:  2012-10-01       Impact factor: 1.137

5.  Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter study.

Authors:  Kazuhide Higuchi; Toshihisa Takeuchi; Noriya Uedo; Yoji Takeuchi; Yuji Naito; Nobuaki Yagi; Kazunari Tominaga; Hirohisa Machida; Takashi Tamada; Yoshinori Morita; Shujiro Yazumi; Junichi Yamao; Mikitaka Iguchi; Takeshi Azuma
Journal:  Gastric Cancer       Date:  2014-08-07       Impact factor: 7.370

6.  Candida albicans infection delays duodenal ulcer healing in cysteamine-induced duodenal ulcers in rats.

Authors:  Longxue Jin; Masashi Yoshida; Tetsuya Nakamura; Hideki Ishikawa; Go Wakabayashi; Minoru Tanabe; Shigeyuki Kawachi; Masahiro Shinoda; Yoshiro Saikawa; Norihito Wada; Kaori Kameyama; Koichiro Kumai; Tetsuro Kubota; Katsuko Sano; Keisuke Nagao; Masayuki Amagai; Yuko Kitagawa; Masaki Kitajima
Journal:  Dig Dis Sci       Date:  2008-07-12       Impact factor: 3.199

Review 7.  Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.

Authors:  Alexander C Ford; Kurinchi Selvan Gurusamy; Brendan Delaney; David Forman; Paul Moayyedi
Journal:  Cochrane Database Syst Rev       Date:  2016-04-19

8.  Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial.

Authors:  Akira Terano; Tetsuo Arakawa; Toshiro Sugiyama; Hidekazu Suzuki; Takashi Joh; Toshikazu Yoshikawa; Kazuhide Higuchi; Ken Haruma; Kazunari Murakami; Kenzo Kobayashi
Journal:  J Gastroenterol       Date:  2007-08-24       Impact factor: 7.527

9.  Strategies for peptic ulcer healing after 1 week proton pump inhibitor-based triple Helicobacter pylori eradication therapy in Japanese patients: differences of gastric ulcers and duodenal ulcers.

Authors:  Toshihisa Takeuchi; Eiji Umegaki; Nozomi Takeuchi; Yukiko Yoda; Yuichi Kojima; Satoshi Tokioka; Kazuhide Higuchi
Journal:  J Clin Biochem Nutr       Date:  2012-06-08       Impact factor: 3.114

10.  Gastric ulcer associated with cytomegalovirus in an immunocompetent patient: method for diagnosis.

Authors:  Chikara Ebisutani; Akira Kawamura; Norihito Shibata; Masamichi Nasu; Rei Ueno; Keiko Mimura; Yoshikazu Kinoshita
Journal:  Case Rep Gastroenterol       Date:  2012-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.